Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Jan 4;292(6512):5–12. doi: 10.1136/bmj.292.6512.5

The natural history of human T lymphotropic virus-III infection: the cause of AIDS.

M Melbye
PMCID: PMC1338969  PMID: 3002536

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiuti F., Rossi P., Sirianni M. C., Carbonari M., Popovic M., Sarngadharan M. G., Contu L., Moroni M., Romagnani S., Gallo R. C. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J (Clin Res Ed) 1985 Jul 20;291(6489):165–166. doi: 10.1136/bmj.291.6489.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alter H. J., Eichberg J. W., Masur H., Saxinger W. C., Gallo R., Macher A. M., Lane H. C., Fauci A. S. Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science. 1984 Nov 2;226(4674):549–552. doi: 10.1126/science.6093251. [DOI] [PubMed] [Google Scholar]
  3. Barin F., McLane M. F., Allan J. S., Lee T. H., Groopman J. E., Essex M. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science. 1985 May 31;228(4703):1094–1096. doi: 10.1126/science.2986291. [DOI] [PubMed] [Google Scholar]
  4. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  5. Bayer H., Bienzle U., Schneider J., Hunsmann G. HTLV-III antibody frequency and severity of lymphadenopathy. Lancet. 1984 Dec 8;2(8415):1347–1347. doi: 10.1016/s0140-6736(84)90862-6. [DOI] [PubMed] [Google Scholar]
  6. Bayley A. C., Downing R. G., Cheingsong-Popov R., Tedder R. S., Dalgleish A. G., Weiss R. A. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet. 1985 Feb 16;1(8425):359–361. doi: 10.1016/s0140-6736(85)91383-2. [DOI] [PubMed] [Google Scholar]
  7. Biggar R. J., Gigase P. L., Melbye M., Kestens L., Sarin P. S., Bodner A. J., Demedts P., Stevens W. J., Paluku L., Delacollette C. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet. 1985 Sep 7;2(8454):520–523. doi: 10.1016/s0140-6736(85)90461-1. [DOI] [PubMed] [Google Scholar]
  8. Biggar R. J., Melbye M., Ebbesen P., Alexander S., Nielsen J. O., Sarin P., Faber V. Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) 1985 Oct 12;291(6501):997–998. doi: 10.1136/bmj.291.6501.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Biggar R. J., Melbye M., Ebbesen P., Mann D. L., Goedert J. J., Weinstock R., Strong D. M., Blattner W. A. Low T-lymphocyte ratios in homosexual men. Epidemiologic evidence for a transmissible agent. JAMA. 1984 Mar 16;251(11):1441–1446. [PubMed] [Google Scholar]
  10. Biggar R. J., Melbye M., Kestems L., Sarngadharan M. G., de Feyter M., Blattner W. A., Gallo R. C., Gigase P. L. Kaposi's sarcoma in Zaire is not associated with HTLV-III infection. N Engl J Med. 1984 Oct 18;311(16):1051–1052. doi: 10.1056/NEJM198410183111612. [DOI] [PubMed] [Google Scholar]
  11. Brun-Vezinet F., Rouzioux C., Barre-Sinoussi F., Klatzmann D., Saimot A. G., Rozenbaum W., Christol D., Gluckmann J. C., Montagnier L., Chermann J. C. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet. 1984 Jun 9;1(8389):1253–1256. doi: 10.1016/s0140-6736(84)92444-9. [DOI] [PubMed] [Google Scholar]
  12. Brun-Vézinet F., Rouzioux C., Montagnier L., Chamaret S., Gruest J., Barré-Sinoussi F., Geroldi D., Chermann J. C., McCormick J., Mitchell S. Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science. 1984 Oct 26;226(4673):453–456. doi: 10.1126/science.6238406. [DOI] [PubMed] [Google Scholar]
  13. Burger H., Weiser B., Robinson W. S., Lifson J., Engleman E., Rouzioux C., Brun-Vézinet F., Barré-Sinoussi F., Montagnier L., Chermann J. C. Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Oct;103(4):545–547. doi: 10.7326/0003-4819-103-4-545. [DOI] [PubMed] [Google Scholar]
  14. Bygbjerg I. C. AIDS in a Danish surgeon (Zaire, 1976) Lancet. 1983 Apr 23;1(8330):925–925. doi: 10.1016/s0140-6736(83)91348-x. [DOI] [PubMed] [Google Scholar]
  15. Carlson J. R., Bryant M. L., Hinrichs S. H., Yamamoto J. K., Levy N. B., Yee J., Higgins J., Levine A. M., Holland P., Gardner M. B. AIDS serology testing in low- and high-risk groups. JAMA. 1985 Jun 21;253(23):3405–3408. [PubMed] [Google Scholar]
  16. Carlson J. R., Hinrichs S. H., Levy N. B., Gardner M. B., Holland P., Pedersen N. C. Evaluation of commercial AIDS screening test kits. Lancet. 1985 Jun 15;1(8442):1388–1388. doi: 10.1016/s0140-6736(85)91809-4. [DOI] [PubMed] [Google Scholar]
  17. Centers for Disease Control (CDC) Hepatitis B vaccine: evidence confirming lack of AIDS transmission. MMWR Morb Mortal Wkly Rep. 1984 Dec 14;33(49):685–687. [PubMed] [Google Scholar]
  18. Centers for Disease Control (CDC) Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR Morb Mortal Wkly Rep. 1985 Sep 20;34(37):561–563. [PubMed] [Google Scholar]
  19. Centers for Disease Control (CDC) Self-reported behavioral change among gay and bisexual men--San Francisco. MMWR Morb Mortal Wkly Rep. 1985 Oct 11;34(40):613–615. [PubMed] [Google Scholar]
  20. Chamberland M. E., Castro K. G., Haverkos H. W., Miller B. I., Thomas P. A., Reiss R., Walker J., Spira T. J., Jaffe H. W., Curran J. W. Acquired immunodeficiency syndrome in the United States: an analysis of cases outside high-incidence groups. Ann Intern Med. 1984 Nov;101(5):617–623. doi: 10.7326/0003-4819-101-5-617. [DOI] [PubMed] [Google Scholar]
  21. Cheingsong-Popov R., Weiss R. A., Dalgleish A., Tedder R. S., Shanson D. C., Jeffries D. J., Ferns R. B., Briggs E. M., Weller I. V., Mitton S. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet. 1984 Sep 1;2(8401):477–480. doi: 10.1016/s0140-6736(84)92562-5. [DOI] [PubMed] [Google Scholar]
  22. Clumck N., Van de Perre P., Caral M., Rouvroy D., Nzaramba D. Heterosexual promiscuity among African patients with AIDS. N Engl J Med. 1985 Jul 18;313(3):182–182. [PubMed] [Google Scholar]
  23. Clumeck N., Sonnet J., Taelman H., Mascart-Lemone F., De Bruyere M., Vandeperre P., Dasnoy J., Marcelis L., Lamy M., Jonas C. Acquired immunodeficiency syndrome in African patients. N Engl J Med. 1984 Feb 23;310(8):492–497. doi: 10.1056/NEJM198402233100804. [DOI] [PubMed] [Google Scholar]
  24. Cooper D. A., Gold J., Maclean P., Donovan B., Finlayson R., Barnes T. G., Michelmore H. M., Brooke P., Penny R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985 Mar 9;1(8428):537–540. doi: 10.1016/s0140-6736(85)91205-x. [DOI] [PubMed] [Google Scholar]
  25. Curran J. W., Lawrence D. N., Jaffe H., Kaplan J. E., Zyla L. D., Chamberland M., Weinstein R., Lui K. J., Schonberger L. B., Spira T. J. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med. 1984 Jan 12;310(2):69–75. doi: 10.1056/NEJM198401123100201. [DOI] [PubMed] [Google Scholar]
  26. Daniel M. D., Letvin N. L., King N. W., Kannagi M., Sehgal P. K., Hunt R. D., Kanki P. J., Essex M., Desrosiers R. C. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science. 1985 Jun 7;228(4704):1201–1204. doi: 10.1126/science.3159089. [DOI] [PubMed] [Google Scholar]
  27. Drew W. L., Mintz L., Miner R. C., Sands M., Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis. 1981 Feb;143(2):188–192. doi: 10.1093/infdis/143.2.188. [DOI] [PubMed] [Google Scholar]
  28. Evatt B. L., Gomperts E. D., McDougal J. S., Ramsey R. B. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. N Engl J Med. 1985 Feb 21;312(8):483–486. doi: 10.1056/NEJM198502213120805. [DOI] [PubMed] [Google Scholar]
  29. Eyster M. E., Goedert J. J., Sarngadharan M. G., Weiss S. H., Gallo R. C., Blattner W. A. Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA. 1985 Apr 19;253(15):2219–2223. [PubMed] [Google Scholar]
  30. Feorino P. M., Jaffe H. W., Palmer E., Peterman T. A., Francis D. P., Kalyanaraman V. S., Weinstein R. A., Stoneburner R. L., Alexander W. J., Raevsky C. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med. 1985 May 16;312(20):1293–1296. doi: 10.1056/NEJM198505163122005. [DOI] [PubMed] [Google Scholar]
  31. Ferroni P., Geroldi D., Galli C., Zanetti A. R., Cargnel A. HTLV-III antibody among Italian drug addicts. Lancet. 1985 Jul 6;2(8445):52–53. doi: 10.1016/s0140-6736(85)90113-8. [DOI] [PubMed] [Google Scholar]
  32. Francis D. P., Feorino P. M., Broderson J. R., McClure H. M., Getchell J. P., McGrath C. R., Swenson B., McDougal J. S., Palmer E. L., Harrison A. K. Infection of chimpanzees with lymphadenopathy-associated virus. Lancet. 1984 Dec 1;2(8414):1276–1277. doi: 10.1016/s0140-6736(84)92824-1. [DOI] [PubMed] [Google Scholar]
  33. Fujikawa L. S., Salahuddin S. Z., Palestine A. G., Masur H., Nussenblatt R. B., Gallo R. C. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet. 1985 Sep 7;2(8454):529–530. doi: 10.1016/s0140-6736(85)90464-7. [DOI] [PubMed] [Google Scholar]
  34. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  35. Goedert J. J., Neuland C. Y., Wallen W. C., Greene M. H., Mann D. L., Murray C., Strong D. M., Fraumeni J. F., Jr, Blattner W. A. Amyl nitrite may alter T lymphocytes in homosexual men. Lancet. 1982 Feb 20;1(8269):412–416. doi: 10.1016/s0140-6736(82)91617-8. [DOI] [PubMed] [Google Scholar]
  36. Goedert J. J., Sarngadharan M. G., Biggar R. J., Weiss S. H., Winn D. M., Grossman R. J., Greene M. H., Bodner A. J., Mann D. L., Strong D. M. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet. 1984 Sep 29;2(8405):711–716. doi: 10.1016/s0140-6736(84)92624-2. [DOI] [PubMed] [Google Scholar]
  37. Goedert J. J., Sarngadharan M. G., Eyster M. E., Weiss S. H., Bodner A. J., Gallo R. C., Blattner W. A. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood. 1985 Feb;65(2):492–495. [PubMed] [Google Scholar]
  38. Groopman J. E., Mayer K. H., Sarngadharan M. G., Ayotte D., Devico A. L., Finberg R., Sliski A. H., Allan J. D., Gallo R. C. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Ann Intern Med. 1985 Mar;102(3):334–337. doi: 10.7326/0003-4819-102-3-334. [DOI] [PubMed] [Google Scholar]
  39. Groopman J. E., Salahuddin S. Z., Sarngadharan M. G., Markham P. D., Gonda M., Sliski A., Gallo R. C. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science. 1984 Oct 26;226(4673):447–449. doi: 10.1126/science.6093247. [DOI] [PubMed] [Google Scholar]
  40. Gürtler L. G., Wernicke D., Eberle J., Zoulek G., Deinhardt F., Schramm W. Increase in prevalence of anti-HTLV-III in haemophiliacs. Lancet. 1984 Dec 1;2(8414):1275–1276. doi: 10.1016/s0140-6736(84)92823-x. [DOI] [PubMed] [Google Scholar]
  41. Hardy A. M., Allen J. R., Morgan W. M., Curran J. W. The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA. 1985 Jan 11;253(2):215–220. [PubMed] [Google Scholar]
  42. Hernandez J. M., Argelagués E., Canivell M. HTLV-III antibody in paid plasma donors in Spain. Lancet. 1985 Jun 15;1(8442):1389–1389. doi: 10.1016/s0140-6736(85)91810-0. [DOI] [PubMed] [Google Scholar]
  43. Hirsch M. S., Wormser G. P., Schooley R. T., Ho D. D., Felsenstein D., Hopkins C. C., Joline C., Duncanson F., Sarngadharan M. G., Saxinger C. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). N Engl J Med. 1985 Jan 3;312(1):1–4. doi: 10.1056/NEJM198501033120101. [DOI] [PubMed] [Google Scholar]
  44. Jaffe H. W., Darrow W. W., Echenberg D. F., O'Malley P. M., Getchell J. P., Kalyanaraman V. S., Byers R. H., Drennan D. P., Braff E. H., Curran J. W. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study. Ann Intern Med. 1985 Aug;103(2):210–214. doi: 10.7326/0003-4819-103-2-210. [DOI] [PubMed] [Google Scholar]
  45. Jaffe H. W., Feorino P. M., Darrow W. W., O'Malley P. M., Getchell J. P., Warfield D. T., Jones B. M., Echenberg D. F., Francis D. P., Curran J. W. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Ann Intern Med. 1985 May;102(5):627–628. doi: 10.7326/0003-4819-102-5-627. [DOI] [PubMed] [Google Scholar]
  46. Jaffe H. W., Sarngadharan M. G., DeVico A. L., Bruch L., Getchell J. P., Kalyanaraman V. S., Haverkos H. W., Stoneburner R. L., Gallo R. C., Curran J. W. Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association. JAMA. 1985 Aug 9;254(6):770–773. [PubMed] [Google Scholar]
  47. Jason J., McDougal J. S., Holman R. C., Stein S. F., Lawrence D. N., Nicholson J. K., Dixon G., Doxey M., Evatt B. L. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage. JAMA. 1985 Jun 21;253(23):3409–3415. [PubMed] [Google Scholar]
  48. Jonckheer T., Dab I., Van de Perre P., Lepage P., Dasnoy J., Taelman H. Cluster of HTLV-III/LAV infection in an African family. Lancet. 1985 Feb 16;1(8425):400–401. doi: 10.1016/s0140-6736(85)91423-0. [DOI] [PubMed] [Google Scholar]
  49. Jones P., Hamilton P. J., Bird G., Fearns M., Oxley A., Tedder R., Cheingsong-Popov R., Codd A. AIDS and haemophilia: morbidity and morality in a well defined population. Br Med J (Clin Res Ed) 1985 Sep 14;291(6497):695–699. doi: 10.1136/bmj.291.6497.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Jones P., Hamilton P. J., Oxley A., Codd A., Tedder R. Anti-HTLV-III positive laboratory reagents. Lancet. 1985 Jun 22;1(8443):1458–1459. doi: 10.1016/s0140-6736(85)91891-4. [DOI] [PubMed] [Google Scholar]
  51. Kalish R. S., Schlossman S. F. The T4 lymphocyte in AIDS. N Engl J Med. 1985 Jul 11;313(2):112–113. doi: 10.1056/NEJM198507113130210. [DOI] [PubMed] [Google Scholar]
  52. Kanki P. J., Alroy J., Essex M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science. 1985 Nov 22;230(4728):951–954. doi: 10.1126/science.2997923. [DOI] [PubMed] [Google Scholar]
  53. Kanki P. J., Kurth R., Becker W., Dreesman G., McLane M. F., Essex M. Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet. 1985 Jun 8;1(8441):1330–1332. doi: 10.1016/s0140-6736(85)92818-1. [DOI] [PubMed] [Google Scholar]
  54. Kestens L., Melbye M., Biggar R. J., Stevens W. J., Piot P., De Muynck A., Taelman H., De Feyter M., Paluku L., Gigase P. L. Endemic African Kaposi's sarcoma is not associated with immunodeficiency. Int J Cancer. 1985 Jul 15;36(1):49–54. doi: 10.1002/ijc.2910360109. [DOI] [PubMed] [Google Scholar]
  55. Kitchen L. W., Barin F., Sullivan J. L., McLane M. F., Brettler D. B., Levine P. H., Essex M. Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature. 1984 Nov 22;312(5992):367–369. doi: 10.1038/312367a0. [DOI] [PubMed] [Google Scholar]
  56. Komuro A., Watanabe T., Miyoshi I., Hayami M., Tsujimoto H., Seiki M., Yoshida M. Detection and characterization of simian retroviruses homologous to human T-cell leukemia virus type I. Virology. 1984 Oct 30;138(2):373–378. doi: 10.1016/0042-6822(84)90364-7. [DOI] [PubMed] [Google Scholar]
  57. Kreiss J. K., Kitchen L. W., Prince H. E., Kasper C. K., Essex M. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission. Ann Intern Med. 1985 May;102(5):623–626. doi: 10.7326/0003-4819-102-5-623. [DOI] [PubMed] [Google Scholar]
  58. Krohn K., Ranki A., Antonen J., Valle S. L., Suni J., Vaheri A., Saxinger C., Gallo R. C. Immune functions in homosexual men with antibodies to HTLV-III in Finland. Clin Exp Immunol. 1985 Apr;60(1):17–24. [PMC free article] [PubMed] [Google Scholar]
  59. L'age-Stehr J., Kunze R., Koch M. A. AIDS in West Germany. Lancet. 1983 Dec 10;2(8363):1370–1371. doi: 10.1016/s0140-6736(83)91131-5. [DOI] [PubMed] [Google Scholar]
  60. Lane H. C., Depper J. M., Greene W. C., Whalen G., Waldmann T. A., Fauci A. S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985 Jul 11;313(2):79–84. doi: 10.1056/NEJM198507113130204. [DOI] [PubMed] [Google Scholar]
  61. Lapointe N., Michaud J., Pekovic D., Chausseau J. P., Dupuy J. M. Transplacental transmission of HTLV-III virus. N Engl J Med. 1985 May 16;312(20):1325–1326. doi: 10.1056/NEJM198505163122012. [DOI] [PubMed] [Google Scholar]
  62. Laurence J., Brun-Vezinet F., Schutzer S. E., Rouzioux C., Klatzmann D., Barré-Sinoussi F., Chermann J. C., Montagnier L. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med. 1984 Nov 15;311(20):1269–1273. doi: 10.1056/NEJM198411153112001. [DOI] [PubMed] [Google Scholar]
  63. Laurence J., Brun-Vezinet F., Schutzer S. E., Rouzioux C., Klatzmann D., Barré-Sinoussi F., Chermann J. C., Montagnier L. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med. 1984 Nov 15;311(20):1269–1273. doi: 10.1056/NEJM198411153112001. [DOI] [PubMed] [Google Scholar]
  64. Letvin N. L., Daniel M. D., Sehgal P. K., Desrosiers R. C., Hunt R. D., Waldron L. M., MacKey J. J., Schmidt D. K., Chalifoux L. V., King N. W. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science. 1985 Oct 4;230(4721):71–73. doi: 10.1126/science.2412295. [DOI] [PubMed] [Google Scholar]
  65. Levy J. A., Hoffman A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oshiro L. S. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science. 1984 Aug 24;225(4664):840–842. doi: 10.1126/science.6206563. [DOI] [PubMed] [Google Scholar]
  66. Levy J. A., Shimabukuro J., Hollander H., Mills J., Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet. 1985 Sep 14;2(8455):586–588. [PubMed] [Google Scholar]
  67. Ludlam C. A., Tucker J., Steel C. M., Tedder R. S., Cheingsong-Popov R., Weiss R. A., McClelland D. B., Philp I., Prescott R. J. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet. 1985 Aug 3;2(8449):233–236. doi: 10.1016/s0140-6736(85)90288-0. [DOI] [PubMed] [Google Scholar]
  68. Madhok R., Melbye M., Lowe G. D., Forbes C. D., Froebel K. S., Bodner A. J., Biggar R. J. HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84. Lancet. 1985 Mar 2;1(8427):524–525. doi: 10.1016/s0140-6736(85)92128-2. [DOI] [PubMed] [Google Scholar]
  69. Mathur-Wagh U., Enlow R. W., Spigland I., Winchester R. J., Sacks H. S., Rorat E., Yancovitz S. R., Klein M. J., William D. C., Mildvan D. Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndrome. Lancet. 1984 May 12;1(8385):1033–1038. doi: 10.1016/s0140-6736(84)91449-1. [DOI] [PubMed] [Google Scholar]
  70. McGrath K. M., Thomas K. B., Herrington R. W., Turner P. J., Taylor L., Ekert H., Schiff P., Gust I. D. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III. Med J Aust. 1985 Jul 8;143(1):11–13. doi: 10.5694/j.1326-5377.1985.tb122758.x. [DOI] [PubMed] [Google Scholar]
  71. Melbye M., Biggar R. J., Chermann J. C., Montagnier L., Stenbjerg S., Ebbesen P. High prevalence of lymphadenopathy virus (LAV) in European haemophiliacs. Lancet. 1984 Jul 7;2(8393):40–41. doi: 10.1016/s0140-6736(84)92023-3. [DOI] [PubMed] [Google Scholar]
  72. Melbye M., Biggar R. J., Ebbesen P., Andersen H. K., Vestergaard B. F. Lifestyle and antiviral antibody studies among homosexual men in Denmark. Acta Pathol Microbiol Immunol Scand B. 1983 Oct;91(5):357–364. doi: 10.1111/j.1699-0463.1983.tb00060.x. [DOI] [PubMed] [Google Scholar]
  73. Melbye M., Biggar R. J., Ebbesen P., Sarngadharan M. G., Weiss S. H., Gallo R. C., Blattner W. A. Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) 1984 Sep 8;289(6445):573–575. doi: 10.1136/bmj.289.6445.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Melbye M., Froebel K. S., Madhok R., Biggar R. J., Sarin P. S., Stenbjerg S., Lowe G. D., Forbes C. D., Goedert J. J., Gallo R. C. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet. 1984 Dec 22;2(8417-8418):1444–1446. doi: 10.1016/s0140-6736(84)91632-5. [DOI] [PubMed] [Google Scholar]
  75. Melbye M., Ingerslev J., Biggar R. J., Alexander S., Sarin P. S., Goedert J. J., Zachariae E., Ebbesen P., Stenbjerg S. Anal intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs. N Engl J Med. 1985 Mar 28;312(13):857–857. doi: 10.1056/NEJM198503283121313. [DOI] [PubMed] [Google Scholar]
  76. Metroka C. E., Cunningham-Rundles S., Pollack M. S., Sonnabend J. A., Davis J. M., Gordon B., Fernandez R. D., Mouradian J. Generalized lymphadenopathy in homosexual men. Ann Intern Med. 1983 Nov;99(5):585–591. doi: 10.7326/0003-4819-99-5-585. [DOI] [PubMed] [Google Scholar]
  77. Mortimer P. P., Vandervelde E. M., Jesson W. J., Pereira M. S., Burkhardt F. HTLV-III antibody in Swiss and English intravenous drug abusers. Lancet. 1985 Aug 24;2(8452):449–450. doi: 10.1016/s0140-6736(85)92771-0. [DOI] [PubMed] [Google Scholar]
  78. Nicholson J. K., McDougal J. S., Jaffe H. W., Spira T. J., Kennedy M. S., Jones B. M., Darrow W. W., Morgan M., Hubbard M. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Ann Intern Med. 1985 Jul;103(1):37–42. doi: 10.7326/0003-4819-103-1-37. [DOI] [PubMed] [Google Scholar]
  79. Phillipson E. A. Humans at high altitude: high altitude and man. Science. 1985 Apr 12;228(4696):171–171. doi: 10.1126/science.228.4696.171. [DOI] [PubMed] [Google Scholar]
  80. Piot P., Quinn T. C., Taelman H., Feinsod F. M., Minlangu K. B., Wobin O., Mbendi N., Mazebo P., Ndangi K., Stevens W. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet. 1984 Jul 14;2(8394):65–69. doi: 10.1016/s0140-6736(84)90241-1. [DOI] [PubMed] [Google Scholar]
  81. Pitchenik A. E., Spira T. J., Elie R., Fischl M. A., Getchell J. P., Arnoux E., Pierre G. D., Laroche A. C., Guerin J. M., Malebranche R. Prevalence of HTLV-III/LAV antibodies among Haitians. N Engl J Med. 1985 Jun 27;312(26):1705–1706. doi: 10.1056/NEJM198506273122609. [DOI] [PubMed] [Google Scholar]
  82. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  83. Ragni M. V., Urbach A. H., Kiernan S., Stambouli J., Cohen B., Rabin B. S., Winkelstein A., Gartner J. C., Zitelli B. Z., Malatack J. J. Acquired immunodeficiency syndrome in the child of a haemophiliac. Lancet. 1985 Jan 19;1(8421):133–135. doi: 10.1016/s0140-6736(85)91904-x. [DOI] [PubMed] [Google Scholar]
  84. Ramsey R. B., Palmer E. L., McDougal J. S., Kalyanaraman V. S., Jackson D. W., Chorba T. L., Holman R. C., Evatt B. L. Antibody to lymphadenopathy-associated virus in haemophiliacs with and without AIDS. Lancet. 1984 Aug 18;2(8399):397–398. doi: 10.1016/s0140-6736(84)90559-2. [DOI] [PubMed] [Google Scholar]
  85. Redfield R. R., Markham P. D., Salahuddin S. Z., Wright D. C., Sarngadharan M. G., Gallo R. C. Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission. JAMA. 1985 Oct 18;254(15):2094–2096. [PubMed] [Google Scholar]
  86. Robertson P. W., Young P. S. HTLV-III antibody in Sydney homosexual men. Med J Aust. 1985 Sep 16;143(6):261–261. doi: 10.5694/j.1326-5377.1985.tb122973.x. [DOI] [PubMed] [Google Scholar]
  87. Rodrigo J. M., Serra M. A., Aguilar E., del Olmo J. A., Gimeno V., Aparisi L. HTLV-III antibodies in drug addicts in Spain. Lancet. 1985 Jul 20;2(8447):156–157. doi: 10.1016/s0140-6736(85)90260-0. [DOI] [PubMed] [Google Scholar]
  88. Safai B., Sarngadharan M. G., Groopman J. E., Arnett K., Popovic M., Sliski A., Schüpbach J., Gallo R. C. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet. 1984 Jun 30;1(8392):1438–1440. doi: 10.1016/s0140-6736(84)91933-0. [DOI] [PubMed] [Google Scholar]
  89. Salahuddin S. Z., Groopman J. E., Markham P. D., Sarngadharan M. G., Redfield R. R., McLane M. F., Essex M., Sliski A., Gallo R. C. HTLV-III in symptom-free seronegative persons. Lancet. 1984 Dec 22;2(8417-8418):1418–1420. doi: 10.1016/s0140-6736(84)91619-2. [DOI] [PubMed] [Google Scholar]
  90. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]
  91. Saxinger W. C., Levine P. H., Dean A. G., de Thé G., Lange-Wantzin G., Moghissi J., Laurent F., Hoh M., Sarngadharan M. G., Gallo R. C. Evidence for exposure to HTLV-III in Uganda before 1973. Science. 1985 Mar 1;227(4690):1036–1038. doi: 10.1126/science.2983417. [DOI] [PubMed] [Google Scholar]
  92. Schneider J., Bayer H., Bienzle U., Wernet P., Hunsmann G. Antibodies to HTLV-III in German blood donors. Lancet. 1985 Feb 2;1(8423):275–276. doi: 10.1016/s0140-6736(85)91050-5. [DOI] [PubMed] [Google Scholar]
  93. Schorr J. B., Berkowitz A., Cumming P. D., Katz A. J., Sandler S. G. Prevalence of HTLV-III antibody in American blood donors. N Engl J Med. 1985 Aug 8;313(6):384–385. doi: 10.1056/NEJM198508083130610. [DOI] [PubMed] [Google Scholar]
  94. Schwartz K., Visscher B. R., Detels R., Taylor J., Nishanian P., Fahey J. L. Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation. Lancet. 1985 Oct 12;2(8459):831–832. doi: 10.1016/s0140-6736(85)90816-5. [DOI] [PubMed] [Google Scholar]
  95. Schüpbach J., Haller O., Vogt M., Lüthy R., Joller H., Oelz O., Popovic M., Sarngadharan M. G., Gallo R. C. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med. 1985 Jan 31;312(5):265–270. doi: 10.1056/NEJM198501313120502. [DOI] [PubMed] [Google Scholar]
  96. Scott G. B., Fischl M. A., Klimas N., Fletcher M. A., Dickinson G. M., Levine R. S., Parks W. P. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA. 1985 Jan 18;253(3):363–366. [PubMed] [Google Scholar]
  97. Scott G. B., Fischl M. A., Klimas N., Fletcher M. A., Dickinson G. M., Levine R. S., Parks W. P. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA. 1985 Jan 18;253(3):363–366. [PubMed] [Google Scholar]
  98. Seidl S., Kühnl P. HTLV-III antibody screening in German blood donors. Lancet. 1985 May 4;1(8436):1047–1047. doi: 10.1016/s0140-6736(85)91650-2. [DOI] [PubMed] [Google Scholar]
  99. Serwadda D., Mugerwa R. D., Sewankambo N. K., Lwegaba A., Carswell J. W., Kirya G. B., Bayley A. C., Downing R. G., Tedder R. S., Clayden S. A. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet. 1985 Oct 19;2(8460):849–852. doi: 10.1016/S0140-6736(85)90122-9. [DOI] [PubMed] [Google Scholar]
  100. Shaw G. M., Hahn B. H., Arya S. K., Groopman J. E., Gallo R. C., Wong-Staal F. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science. 1984 Dec 7;226(4679):1165–1171. doi: 10.1126/science.6095449. [DOI] [PubMed] [Google Scholar]
  101. Shaw G. M., Harper M. E., Hahn B. H., Epstein L. G., Gajdusek D. C., Price R. W., Navia B. A., Petito C. K., O'Hara C. J., Groopman J. E. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11;227(4683):177–182. doi: 10.1126/science.2981429. [DOI] [PubMed] [Google Scholar]
  102. Stewart G. J., Tyler J. P., Cunningham A. L., Barr J. A., Driscoll G. L., Gold J., Lamont B. J. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet. 1985 Sep 14;2(8455):581–585. doi: 10.1016/s0140-6736(85)90585-9. [DOI] [PubMed] [Google Scholar]
  103. Thomas P. A., Jaffe H. W., Spira T. J., Reiss R., Guerrero I. C., Auerbach D. Unexplained immunodeficiency in children. A surveillance report. JAMA. 1984 Aug 3;252(5):639–644. [PubMed] [Google Scholar]
  104. Tsoukas C., Gervais F., Shuster J., Gold P., O'Shaughnessy M., Robert-Guroff M. Association of HTLV-III antibodies and cellular immune status of hemophiliacs. N Engl J Med. 1984 Dec 6;311(23):1514–1515. doi: 10.1056/NEJM198412063112312. [DOI] [PubMed] [Google Scholar]
  105. Tucker J., Ludlam C. A., Craig A., Philp I., Steel C. M., Tedder R. S., Cheingsong-Popov R., Macnicol M. F., McClelland D. B., Boulton F. E. HTLV-III infection associated with glandular-fever-like illness in a haemophiliac. Lancet. 1985 Mar 9;1(8428):585–585. doi: 10.1016/s0140-6736(85)91247-4. [DOI] [PubMed] [Google Scholar]
  106. Van de Perre P., Clumeck N., Carael M., Nzabihimana E., Robert-Guroff M., De Mol P., Freyens P., Butzler J. P., Gallo R. C., Kanyamupira J. B. Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III. Lancet. 1985 Sep 7;2(8454):524–527. doi: 10.1016/s0140-6736(85)90462-3. [DOI] [PubMed] [Google Scholar]
  107. Van de Perre P., Munyambuga D., Zissis G., Butlzer J. P., Nzaramba D., Clumeck N. Antibody to HTLV-III in blood donors in central Africa. Lancet. 1985 Feb 9;1(8424):336–337. doi: 10.1016/s0140-6736(85)91104-3. [DOI] [PubMed] [Google Scholar]
  108. Vandepitte J., Verwilghen R., Zachee P. AIDS and cryptococcosis (Zaire, 1977) Lancet. 1983 Apr 23;1(8330):925–926. doi: 10.1016/s0140-6736(83)91349-1. [DOI] [PubMed] [Google Scholar]
  109. Vilmer E., Barre-Sinoussi F., Rouzioux C., Gazengel C., Brun F. V., Dauguet C., Fischer A., Manigne P., Chermann J. C., Griscelli C. Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet. 1984 Apr 7;1(8380):753–757. doi: 10.1016/s0140-6736(84)91275-3. [DOI] [PubMed] [Google Scholar]
  110. Vilmer E., Fischer A., Griscelli C., Barre-Sinoussi F., Vie V., Chermann J. C., Montagnier L., Rouzioux C., Brun-Vezinet F., Rosenbaum W. Possible transmission of a human lymphotropic retrovirus (LAV) from mother to infant with AIDS. Lancet. 1984 Jul 28;2(8396):229–230. doi: 10.1016/s0140-6736(84)90519-1. [DOI] [PubMed] [Google Scholar]
  111. Weiss S. H., Goedert J. J., Sarngadharan M. G., Bodner A. J., Gallo R. C., Blattner W. A. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA. 1985 Jan 11;253(2):221–225. [PubMed] [Google Scholar]
  112. Weiss S. H., Saxinger W. C., Rechtman D., Grieco M. H., Nadler J., Holman S., Ginzburg H. M., Groopman J. E., Goedert J. J., Markham P. D. HTLV-III infection among health care workers. Association with needle-stick injuries. JAMA. 1985 Oct 18;254(15):2089–2093. [PubMed] [Google Scholar]
  113. Wendel S. N., Russo C., Bertoni R. R., Tsunoda N. M., Ghaname J. N. AIDS and blood donors in Brazil. Lancet. 1985 Aug 31;2(8453):506–506. doi: 10.1016/s0140-6736(85)90443-x. [DOI] [PubMed] [Google Scholar]
  114. Ziegler J. B., Cooper D. A., Johnson R. O., Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet. 1985 Apr 20;1(8434):896–898. doi: 10.1016/s0140-6736(85)91673-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES